Sign Up to like & get
recommendations!
1
Published in 2020 at "Archives of Disease in Childhood"
DOI: 10.1136/archdischild-2020-rcpch.21
Abstract: Aims Report onasemnogene abeparvovec (formerly AVXS101) GRT development for SMA. Onasemnogene abeparvovec is a one-time, intravenous GRT that addresses the genetic root cause of SMA, a progressive neurological disease. Onasemnogene abeparvovec delivers the survival motor…
read more here.
Keywords:
improving survival;
g32 improving;
onasemnogene abeparvovec;
cohort ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "eLife"
DOI: 10.7554/elife.48145
Abstract: The survival of patients with cutaneous melanoma can be accurately predicted using just four DNA methylation marks.
read more here.
Keywords:
survival prediction;
prediction melanoma;
improving survival;